ReviewMedical molecular morphology2006
Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B.
Review in Medical molecular morphology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Molecular Epidemiology of Hepatitis B Virus in Turkish Cypriot.Polish journal of microbiology · 2019Article
- HBV Core Protein Enhances Cytokine Production.Diseases (Basel, Switzerland) · 2015Article
- The analysis of correlation between IL-12 gene expression and hepatitis B virus in the affected patients.Virusdisease · 2015Article
- Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2015Article
- Modulation of the unfolded protein response by the human hepatitis B virus.Frontiers in microbiology · 2014Review
- Article
- Epigenetic mechanisms in virus-induced tumorigenesis.Clinical epigenetics · 2011Article
- Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment.Journal of virology · 2011Article
- Development of a sensitive enzyme-linked immunosorbent assay for detection of hepatitis B surface antigen using novel monoclonal antibodies.Avicenna journal of medical biotechnology · 2010Article
- Viral epigenomes in human tumorigenesis.Oncogene · 2010Review
- Hepatitis B virus (HBV) and autoimmune disease.Clinical reviews in allergy & immunology · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis B virus (HBV) is a major cause of liver disease worldwide. It is covered with envelope (surface antigen) proteins with the nucleocapsid (core antigen) inside. In the nucleocapsid, there is an incomplete double-stranded DNA and a DNA polymerase. Four genes, S, C, X, and P, are encoded, and these partially overlap. Mutations have been reported in each gene and in their promoter regions, and these mutations can change the efficiency of HBV replication and the clinical course of patients. In this article, we review the relationship between the molecular biology of HBV and its clinical outcome.
Indexed as
Identifiers
16998621What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.